{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:15:50Z","timestamp":1707524150325},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,25]]},"DOI":"10.7759\/cureus.11146","type":"journal-article","created":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T07:57:30Z","timestamp":1603612650000},"source":"Crossref","is-referenced-by-count":0,"title":["Impact of Fasting Lipid Profile on Chronic Kidney Disease Patients Having Fatty Liver Disease"],"prefix":"10.7759","author":[{"given":"Muhammad Sohaib","family":"Asghar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maira","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uzma","family":"Rasheed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Jawad","family":"Haider Kazmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noman A","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faran","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha","family":"Anum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saira","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/847539","article-title":"Chronic kidney disease and nonalcoholic fatty liver disease-is there a link?","volume":"2014","author":"Orli\u0107 L","year":"2014","unstructured":"Orli\u0107 L, Mikolasevic I, Bagic Z, Racki S, Stimac D, Milic S. Chronic kidney disease and nonalcoholic fatty liver disease-is there a link?. Gastroenterol Res Pract. 2014, 2014:1-6. 10.1155\/2014\/847539","journal-title":"Gastroenterol Res Pract"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-019097","article-title":"Fatty liver index, albuminuria and the association with chronic kidney disease: a population-based study in China","volume":"8","author":"Sun K","year":"2018","unstructured":"Sun K, Lin D, Li F, et al.. Fatty liver index, albuminuria and the association with chronic kidney disease: a population-based study in China. BMJ Open. 2018, 8:1-9. 10.1136\/bmjopen-2017-019097","journal-title":"BMJ Open"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.18203\/2320-6012.ijrms20192513","article-title":"A study of fasting lipid profile in chronic kidney disease patients","volume":"7","author":"Singh S","year":"2019","unstructured":"Singh S, Pathak AK, Parappanavar NU. A study of fasting lipid profile in chronic kidney disease patients. Int J Res Med Sci. 2019, 7:2282-2285. 10.18203\/2320-6012.ijrms20192513","journal-title":"Int J Res Med Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005121320","article-title":"Lipids and renal disease","volume":"17","author":"Trevisan R","year":"2006","unstructured":"Trevisan R, Dodesini AR, Lepore G. Lipids and renal disease. J Am Soc Nephrol. 2006, 17:145-147. 10.1681\/ASN.2005121320","journal-title":"J Am Soc Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/IJNRD.S101808","article-title":"Dyslipidemia in patients with chronic kidney disease: etiology and management","volume":"10","author":"Mikolasevic I","year":"2017","unstructured":"Mikolasevic I, \u017dutelija M, Mavrinac V, Orlic L. Dyslipidemia in patients with chronic kidney disease: etiology and management. Int J Nephrol Renovasc Dis. 2017, 10:35-45. 10.2147\/IJNRD.S101808","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne CD","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015, 62:47-64. 10.1016\/j.jhep.2014.12.012","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo P","year":"2002","unstructured":"Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002, 346:1221-1231. 10.1056\/NEJMra011775","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i47.8263","article-title":"Clinical epidemiology and disease burden of nonalcoholic fatty liver disease","volume":"23","author":"Perumpail BJ","year":"2017","unstructured":"Perumpail BJ, Khan MA, Yoo ER, et al.. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. World J Gastroenterol. 2017, 23:8263-8276. 10.3748\/wjg.v23.i47.8263","journal-title":"World J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi ZM","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016, 64:73-84. 10.1002\/hep.28431","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002484","article-title":"Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation","volume":"103","author":"Younossi ZM","year":"2019","unstructured":"Younossi ZM, Marchesini G, Pinto-Cortez H. Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation. Transplantation. 2019, 103:22-27. 10.1097\/TP.0000000000002484","journal-title":"Transplantation"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2012.200","article-title":"Physical activity: an essential component of lifestyle modification in NAFLD","volume":"9","author":"Rodriguez B","year":"2012","unstructured":"Rodriguez B, Torres DM, Harrison SA. Physical activity: an essential component of lifestyle modification in NAFLD. Nat Rev Gastroenterol Hepatol. 2012, 9:726-731. 10.1038\/nrgastro.2012.200","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"6","author":"Marchesini G","year":"2016","unstructured":"Marchesini G, Day CP, Dufour JF, et al.. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016, 6:1388-1402. 10.1016\/j.jhep.2015.11.004","journal-title":"J Hepatol"},{"key":"ref13","article-title":"Is there any consensus as to what diet or lifestyle approach is the right one for NAFLD patients?","volume":"21","author":"Finelli C","year":"2012","unstructured":"Finelli C, Tarantino G. Is there any consensus as to what diet or lifestyle approach is the right one for NAFLD patients?. J Gastrointestin Liver Dis. 2012, 21:293-302.","journal-title":"J Gastrointestin Liver Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0b013e328357f747","article-title":"Vitamin E and nonalcoholic fatty liver disease","volume":"15","author":"Pacana T","year":"2012","unstructured":"Pacana T, Sanyal AJ. Vitamin E and nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care. 2012, 15:641-648. 10.1097\/MCO.0b013e328357f747","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(00)05040-X","article-title":"Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study","volume":"136","author":"Lavine JE","year":"2000","unstructured":"Lavine JE. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatr. 2000, 136:734-748. 10.1016\/S0022-3476(00)05040-X","journal-title":"J Pediatr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22402","article-title":"Statins in liver disease: a molehill, an iceberg, or neither?","volume":"48","author":"Argo CK","year":"2008","unstructured":"Argo CK, Loria P, Caldwell SH, et al.. Statins in liver disease: a molehill, an iceberg, or neither?. Hepatology. 2008, 48:1-8. 10.1002\/hep.22402","journal-title":"Hepatology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2014.04.002","article-title":"Statin therapy is associated with a reduced risk of non-alcoholic fatty liver in overweight individuals","volume":"46","author":"de Keyser CE","year":"2014","unstructured":"de Keyser CE, Koehler EM, Schouten JN, et al.. Statin therapy is associated with a reduced risk of non-alcoholic fatty liver in overweight individuals. Dig Liver Dis. 2014, 46:720-725. 10.1016\/j.dld.2014.04.002","journal-title":"Dig Liver Dis"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1055\/s-0028-1091984","article-title":"Current and emerging therapies in nonalcoholic fatty liver disease","volume":"28","author":"Kashi MR","year":"2008","unstructured":"Kashi MR, Torres M, Harrison SA. Current and emerging therapies in nonalcoholic fatty liver disease. Semin Liver Dis. 2008, 28:396-406.","journal-title":"Semin Liver Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/nu11112820","article-title":"Cholesterol disturbances and the role of proper nutrition in CKD patients","volume":"11","author":"Gluba-Brzozka A","year":"2019","unstructured":"Gluba-Brzozka A, Franczyk B, Rysz J. Cholesterol disturbances and the role of proper nutrition in CKD patients. Nutrients. 2019, 11:1-30. 10.3390\/nu11112820","journal-title":"Nutrients"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/toxins8120376","article-title":"Modified lipids and lipoproteins in chronic kidney disease: a new class of uremic toxins","volume":"8","author":"Florens N","year":"2016","unstructured":"Florens N, Calzada C, Lyasko E, Juillard L, Soulage CO. Modified lipids and lipoproteins in chronic kidney disease: a new class of uremic toxins. Toxins. 2016, 8:1-27. 10.3390\/toxins8120376","journal-title":"Toxins"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1159\/000488816","article-title":"Disorders of lipid metabolism in chronic kidney disease","volume":"46","author":"Bulbul MC","year":"2018","unstructured":"Bulbul MC, Dagel T, Afsar B, et al.. Disorders of lipid metabolism in chronic kidney disease. Blood Purif. 2018, 46:144-152. 10.1159\/000488816","journal-title":"Blood Purif"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2015.06.028","article-title":"Cholesterol metabolism in CKD","volume":"66","author":"Reiss AB","year":"2015","unstructured":"Reiss AB, Voloshyna I, De Leon J, Miyawaki N, Mattana J. Cholesterol metabolism in CKD. Am J Kid Dis. 2015, 66:1071-1082. 10.1053\/j.ajkd.2015.06.028","journal-title":"Am J Kid Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i43.9488","article-title":"Nonalcoholic fatty liver disease-a multisystem disease?","volume":"22","author":"Mikolasevic I","year":"2016","unstructured":"Mikolasevic I, Milic S, Wensveen TT, et al.. Nonalcoholic fatty liver disease-a multisystem disease?. World J Gastroenterol. 2016, 22:9488-9505. 10.3748\/wjg.v22.i43.9488","journal-title":"World J Gastroenterol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17040562","article-title":"NAFLD and chronic kidney disease","volume":"17","author":"Marcuccilli M","year":"2016","unstructured":"Marcuccilli M, Chonchol M. NAFLD and chronic kidney disease. Int J Mol Sci. 2016, 17:1-15. 10.3390\/ijms17040562","journal-title":"Int J Mol Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001680","article-title":"Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis","volume":"11","author":"Musso G","year":"2014","unstructured":"Musso G, Gambino R, Tabibian JH, et al.. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. PLoS Med. 2014, 11:1-27. 10.1371\/journal.pmed.1001680","journal-title":"PLoS Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0231328","article-title":"Lipid profiles and risk of major adverse cardiovascular events in CKD and diabetes: a nationwide population-based study","volume":"15","author":"Lee Y","year":"2020","unstructured":"Lee Y, Park S, Lee S, et al.. Lipid profiles and risk of major adverse cardiovascular events in CKD and diabetes: a nationwide population-based study. PLoS ONE. 2020, 15:1-14. 10.1371\/journal.pone.0231328","journal-title":"PLoS ONE"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23014-0","article-title":"Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study","volume":"8","author":"Jang HR","year":"2018","unstructured":"Jang HR, Kang D, Sinn DH, et al.. Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study. Sci Rep. 2018, 8:1-9. 10.1038\/s41598-018-23014-0","journal-title":"Sci Rep"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.14260\/jemds\/2018\/439","article-title":"Hepatic enzymes changes in chronic kidney disease patients- a need for modified reference values","volume":"7","author":"Latiwesh OB","year":"2018","unstructured":"Latiwesh OB, Younis MYG, Shakila S, et al.. Hepatic enzymes changes in chronic kidney disease patients- a need for modified reference values. J Evolution Med Dent Sci. 2018, 7:1949-1954. 10.14260\/jemds\/2018\/439","journal-title":"J Evolution Med Dent Sci"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-1182","article-title":"Fatty liver and chronic kidney disease: novel mechanistic insights and therapeutic opportunities","volume":"39","author":"Musso G","year":"2016","unstructured":"Musso G, Cassader M, Cohney S, et al.. Fatty liver and chronic kidney disease: novel mechanistic insights and therapeutic opportunities. Diabetes Care. 2016, 39:1830-1845. 10.2337\/dc15-1182","journal-title":"Diabetes Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/41110-impact-of-fasting-lipid-profile-on-chronic-kidney-disease-patients-having-fatty-liver-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:19:26Z","timestamp":1707506366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/41110-impact-of-fasting-lipid-profile-on-chronic-kidney-disease-patients-having-fatty-liver-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,25]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.11146","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,25]]}}}